Profile data is unavailable for this security.
About the company
NanoVibronix, Inc. is a medical device company. The Company develops medical devices utilizing its patented low intensity surface acoustic wave technology. Its products include UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use. UroShield Ultra is similar to UroShield, but is designed to prevent bacterial colonization and biofilm formation in urinary catheters. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD, PainShield Plus and WoundShield. WoundShield is a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing.
- Revenue in USD (TTM)2.28m
- Net income in USD-3.71m
- Incorporated2003
- Employees10.00
- LocationNanovibronix Inc525 Executive BlvdELMSFORD 10523United StatesUSA
- Phone+1 (914) 233-3004
- Websitehttps://nanovibronix.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Grapefruit USA Inc | 34.85k | -4.37m | 1.44m | 9.00 | -- | -- | -- | 41.28 | -0.008 | -0.008 | 0.00006 | -0.0101 | 0.0121 | 1.31 | 0.2259 | 3,872.22 | -151.85 | -268.93 | -- | -- | -1,304.65 | -10.09 | -12,531.68 | -408.87 | 0.0388 | -1.50 | -- | -- | -83.96 | 77.87 | -35.68 | -- | -- | -- |
| Escalon Medical Corp | 12.38m | 450.50k | 1.48m | 38.00 | 7.72 | 1.58 | 2.99 | 0.1198 | 0.0259 | 0.0259 | 1.18 | 0.1951 | 2.65 | 4.04 | 8.01 | 325,898.70 | 14.68 | -1.76 | 35.71 | -3.67 | 46.26 | 44.57 | 5.54 | -0.9114 | 1.09 | 31.90 | 0.1504 | -- | 13.80 | 1.33 | 760.89 | -17.06 | -19.85 | -- |
| Tivic Health Systems Inc | 1.23m | -8.26m | 1.53m | 16.00 | -- | 0.2659 | -- | 1.25 | -42.45 | -42.45 | 2.75 | 3.93 | 0.1613 | 1.07 | 10.86 | 76,687.50 | -108.51 | -- | -135.42 | -- | 26.49 | -- | -672.78 | -- | 5.53 | -- | 0.00 | -- | 46.38 | -- | -18.86 | -- | -- | -- |
| Bone Biologics Corp | 0.00 | -8.95m | 1.63m | 2.00 | -- | 0.3401 | -- | -- | -77.05 | -77.05 | 0.00 | 5.44 | 0.00 | -- | -- | 0.00 | -146.30 | -98.31 | -202.15 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -502.76 | -- | -- | -- |
| Prosomnus Inc | 25.61m | -15.02m | 1.91m | 129.00 | -- | -- | -- | 0.0747 | -0.942 | -0.942 | 1.52 | -1.33 | 1.20 | 11.86 | 8.85 | 198,496.50 | -70.44 | -- | -164.95 | -- | 52.38 | -- | -58.65 | -- | 1.38 | -3.15 | 2.57 | -- | 37.79 | -- | -19.54 | -- | -- | -- |
| NanoVibronix Inc | 2.28m | -3.71m | 2.05m | 10.00 | -- | 0.3777 | -- | 0.8976 | -2.15 | -2.15 | 1.30 | 1.95 | 0.3637 | 0.3041 | 13.96 | 228,300.00 | -59.13 | -116.16 | -95.36 | -169.36 | 67.32 | 50.47 | -162.55 | -570.47 | 1.53 | -13.97 | 0.00 | -- | 203.59 | 48.33 | 31.88 | -- | -34.02 | -- |
| InnerScope Hearing Technologies, Inc. | 334.45k | -7.15m | 2.14m | 24.00 | -- | -- | -- | 6.40 | -0.0153 | -0.0153 | 0.0002 | -0.0028 | 0.0955 | 3.93 | 1.71 | -- | -204.11 | -27.82 | -- | -94.53 | 17.79 | 58.17 | -2,138.50 | -42.13 | 0.0022 | -0.4232 | -- | -- | -- | 100.59 | -- | -- | 233.50 | -- |
| Dynatronics Corp | 35.18m | -5.70m | 2.20m | 154.00 | -- | 0.2705 | -- | 0.0626 | -1.38 | -1.38 | 8.39 | 3.43 | 1.09 | 3.16 | 7.84 | 228,421.30 | -15.46 | -6.02 | -21.69 | -8.30 | 21.52 | 27.33 | -14.12 | -4.55 | 0.6695 | -19.74 | 0.1955 | -- | -8.41 | -8.81 | -19.84 | -- | -5.11 | -- |
| VirExit Technologies Inc | 0.00 | -1.80m | 2.28m | -- | -- | -- | -- | -- | -0.0932 | -0.113 | 0.00 | -0.0367 | 0.00 | -- | -- | -- | -6,103.43 | -- | -- | -- | -- | -- | -- | -- | -- | -3.66 | -- | -- | -100.00 | -- | 19.08 | -- | -- | -- |
| SINTX Technologies Inc | 2.63m | -8.29m | 2.40m | 43.00 | -- | 0.0285 | -- | 0.9119 | -2.03 | -2.03 | 0.7041 | 1.65 | 0.1687 | 1.34 | 5.19 | 61,093.02 | -53.05 | -45.71 | -81.96 | -57.36 | 70.16 | 58.47 | -314.39 | -681.80 | 1.60 | -- | 0.0052 | -- | 68.29 | 94.24 | 49.75 | -- | 54.10 | -- |
| Invo Bioscience Inc | 3.02m | -8.03m | 2.54m | 25.00 | -- | -- | -- | 0.8399 | -9.13 | -9.13 | 2.57 | 0.3582 | 0.2417 | 6.73 | 27.75 | 120,822.80 | -64.30 | -94.63 | -120.25 | -151.45 | 41.20 | 74.91 | -266.00 | -343.11 | 0.1211 | -6.86 | 0.7558 | -- | 267.38 | 43.62 | 26.24 | -- | 87.09 | -- |
| Therapeutic Solutions International Inc | 98.99k | -2.17m | 2.54m | 3.00 | -- | 2.03 | -- | 25.64 | -0.0007 | -0.0007 | 0.00003 | 0.0003 | 0.0287 | 1.13 | 4.44 | 32,996.67 | -64.51 | -162.32 | -169.11 | -- | 62.85 | 67.79 | -2,247.41 | -2,391.85 | 0.0333 | -4.92 | 0.373 | -- | -52.13 | 95.35 | 43.11 | -- | -- | -- |
| Helius Medical Technologies Inc | -100.00bn | -100.00bn | 2.55m | 26.00 | -- | 0.8727 | -- | -- | -- | -- | -- | 3.29 | -- | -- | -- | -- | -- | -98.37 | -- | -143.57 | -- | 37.27 | -- | -1,580.66 | 3.72 | -- | -- | -- | -18.17 | 6.14 | 37.11 | -- | -- | -- |
| Nuwellis Inc | 8.86m | -22.63m | 2.74m | 59.00 | -- | 0.3421 | -- | 0.3091 | -13.45 | -13.45 | 4.51 | 0.5651 | 0.5147 | 1.67 | 5.28 | 150,237.30 | -117.35 | -98.07 | -152.04 | -122.48 | 56.22 | 55.22 | -227.99 | -230.51 | 1.96 | -5.06 | 0.00 | -- | 3.76 | 12.14 | -55.78 | -- | 4.61 | -- |
| Vycor Medical Inc | 1.46m | -387.45k | 2.74m | 8.00 | -- | -- | -- | 1.88 | -0.0122 | -0.0124 | 0.0432 | -0.1019 | 1.58 | 0.6002 | 7.86 | 182,575.00 | -6.81 | -47.86 | -- | -- | 90.08 | 89.60 | -4.32 | -35.42 | 0.0859 | 0.389 | -- | -- | 19.43 | -0.6542 | 46.49 | -- | -31.77 | -- |
Data as of May 03 2024. Currency figures normalised to Nanovibronix Inc's reporting currency: US Dollar USD
5.24%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Renaissance Technologies LLCas of 31 Dec 2023 | 41.20k | 2.01% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 30.19k | 1.48% |
| Geode Capital Management LLCas of 31 Dec 2023 | 14.46k | 0.71% |
| AmTrust Financial Services, Inc. (Investment Portfolio)as of 31 Dec 2023 | 12.41k | 0.61% |
| Tower Research Capital LLCas of 31 Dec 2023 | 5.26k | 0.26% |
| UBS Securities LLCas of 31 Dec 2023 | 3.54k | 0.17% |
| National Bank Financial, Inc.as of 31 Dec 2023 | 110.00 | 0.01% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 74.00 | 0.00% |
| Wells Fargo Bank, NA (Private Banking)as of 31 Dec 2023 | 13.00 | 0.00% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2023 | 10.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
